Increased oral bioavailability of Salmon Calcitonin

Aug 10, 2020 | Medicines

Salmon Calcitonin is currently administered by injection for the treatment of osteoporosis in postmenopausal women. An oral dosage form is not available due to its poor oral bioavailability. Scientists have applied technologies to overcome duodenal and sublingual...

EU approval of the first triple combination for asthma

Jul 22, 2020 | Medicines

The drug belonging to the DPI group administered in hard capsules consists of the ingredients indacaterol/glycopyrronium/mometasone (114 µg / 46 µg / 68 µg). This fixed tri-therapy is used in patients with insufficiently controlled asthma with a combination of a...

New oral formulation with Diclofenac

Jul 21, 2020 | Innovation, Medicines

In France, 50 mg of diclofenac epolamine granules for oral suspension in sachets have been granted marketing authorisation and are now available. The field of application extends over: short-term symptomatic treatment of acute seizures of extraarticular rheumatism...

Why a market analysis of your own market is so important

Jul 9, 2020 | Medicines

A market analysis is usually considered superfluous, here are a few reasons to change your mind: Markets and customers, and/or the top 10 diseases are changing: A market analysis helps to uncover the sometimes slow, sometimes fast changes in the market and not to lose...